Table 2.

Perceived Impact of Variables on EDA (n = 135)

Patient Variable	Impact (%)			Addressed in Institutional Policy (%; n = 34)
	High to Very High	Moderate	None to Low
Degree of obesity	69.7	17	13.3	80.8
CM*	67.9	23.7	8.4	53.8
PS	59.9	30.3	9.9	30.8
Age	48.1	32.3	19.6	26.9
Curative intent	78	16.7	5.3	50
Pharmacokinetic properties	49.6	34.6	15.8	26.9
Route of administration	18.8	37.6	43.6	23.1
Type of medication†	45.1	30.5	24.5	50

Abbreviations: EDA, empiric dose adjustment; CM, comorbidity; PS, performance status.

^*Excluding renal or hepatic dysfunction.

^†Targeted ν cytotoxic chemotherapy.